c-Jun N-terminal kinase regulates apoptosis in endometrial cancer cells
Elaine M Reno1, James M Haughian, Twila A Jackson
1Department of Obstetrics and Gynecology, Section of Basic Reproductive Sciences, School of Medicine, University of Colorado Denver, Mail Stop 8309, 12800 E. 19th Avenue, Aurora, CO 80045, USA.
Abstract:
c-Jun N-terminal kinases (JNKs) are important regulators of cell proliferation and apoptosis that have been implicated in tumorigenesis. We investigated the role of JNKs in apoptotic responses in Ishikawa and HEC-50 cells, models of type I and type II endometrial cancer, respectively. Etoposide treatment or UV irradiation resulted in sustained activation of JNK, correlating with the induction of apoptosis. Inhibition of JNK, or MAP kinase kinase 4 (MKK4), selectively suppressed apoptotic responses in both Ishikawa and HEC-50 cells. Knockdown of protein kinase C delta (PKCdelta) also attenuated apoptosis in endometrial cancer cells and inhibited the sustained, UV-mediated JNK activation in HEC-50, but not Ishikawa cells. Etoposide-induced JNK phosphorylation was unaffected by PKCdelta knockdown, implying that JNK can regulate apoptosis by PKCdelta-dependent and independent pathways, according to stimulus and cell type. Thus, expression and activity of JNK and PKCdelta in endometrial cancer cells modulate apoptosis and sensitivity to chemotherapeutic agents and may function as tumor suppressors in the endometrium.
Insights
c-Jun N-terminal kinases (JNKs) and protein kinase C delta (PKCdelta) regulate apoptosis in endometrial cancer. Their activity influences sensitivity to chemotherapy, suggesting a tumor suppressor role.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Research
Background:
- c-Jun N-terminal kinases (JNKs) are key regulators of cell proliferation and apoptosis, implicated in tumorigenesis.
- Endometrial cancer presents distinct subtypes (Type I and Type II) with varying cellular mechanisms.
Purpose of the Study:
- To investigate the role of JNKs in apoptotic responses in Type I (Ishikawa) and Type II (HEC-50) endometrial cancer cells.
- To explore the interplay between JNK, MAP kinase kinase 4 (MKK4), and protein kinase C delta (PKCdelta) in regulating apoptosis and chemoresistance.
Main Methods:
- Utilized etoposide treatment and UV irradiation to induce JNK activation and apoptosis in endometrial cancer cell lines.
- Employed JNK and MKK4 inhibition, alongside PKCdelta knockdown, to assess their impact on apoptotic pathways.
- Differentiated between stimulus-dependent and cell-type-specific signaling pathways.
Main Results:
- Sustained JNK activation correlated with apoptosis induction following etoposide or UV treatment.
- Inhibition of JNK or MKK4 selectively suppressed apoptosis in both cell types.
- PKCdelta knockdown attenuated apoptosis and affected UV-mediated JNK activation in HEC-50 cells, but not Ishikawa cells, indicating stimulus and cell-type-specific roles.
Conclusions:
- JNK regulates apoptosis via both PKCdelta-dependent and independent pathways, contingent on the stimulus and cell type.
- JNK and PKCdelta expression and activity in endometrial cancer cells modulate apoptosis and chemosensitivity.
- These kinases may function as tumor suppressors in endometrial cancer, impacting therapeutic strategies.
Related Concept Videos
The Intrinsic Apoptotic Pathway
MAPK Signaling Cascades
The Extrinsic Apoptotic Pathway
Inhibition of Cdk Activity
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
